Eptifibatide is a synthetic cyclic peptide that functions as a platelet glycoprotein IIb/IIIa inhibitor, used to prevent clot formation in acute coronary syndromes and during percutaneous coronary intervention. The term designates a pharmacological agent with a specialized medical purpose, typically encountered in clinical or pharmacology contexts. Its pronunciation is often the focus of clinicians and medical students when encountering this drug name in literature and patient education materials.
Full pronunciation guide
